Attana
0,007
SEK
0 %
ATANA
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
1 investor følger denne virksomhed
0%
-66,67%
-84,85%
-85,56%
-87,46%
-85,89%
-98,31%
-98,05%
-95,45%
Attana conducts research and development of pharmaceuticals. The company specialises in vitro characterization of molecular interactions, which is used for analysis in the development of new pharmaceuticals. The company's patented solutions are mainly used in the study of different binding properties and macrostructures in cells, proteins, viruses, and bacteria. Operations are found mainly within the Nordic countries and Europe. The company was established in 2002 is based in Stockholm.
Læs mereMarkedsværdi
9,65 mio. SEK
Aktieomsætning
102,01 t SEK
Omsætning
5,05 mio.
EBIT %
-245,74 %
P/E
-
Udbytteafkast, %
-
Finanskalender
21.2
2025
Årsrapport '24
9.5
2025
Generalforsamling '24
9.5
2025
Delårsrapport Q1'25
ViserAlle indholdstyper
Attana enters the third year of a five-year service and support contract with a leading health institute in the US
New paper using Attana tecnology to understand how viruses enter human cells
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools